In addition, polymorphisms in suspected modifier genes including Jagged1 in mildly affected golden retriever dogs [7] and LTBP4 in human DMD patients [8], are thought to influence the clinical dystrophic phenotype. This evidence concerns the gene LTBP4 and Duchenne muscular dystrophy.